Evidence map›Paper›PMID 25968177›Full record

ArticleBMC psychiatry2015

Autism beyond diagnostic categories: characterization of autistic phenotypes in schizophrenia.

Anne Kästner, Martin Begemann, Tanja Maria Michel, Sarah Everts, Beata Stepniak, Christiane Bach, Luise Poustka, Joachim Becker, Tobias Banaschewski, Matthias Dose and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC psychiatry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 3 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 3 syntheses or guidelines pooled it, 99 citations in OpenAlex.

  1. Autism spectrum disorder and schizophrenia: An updated conceptual review.Autism research : official journal of the International Society for Autism Research · 2022
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. What autism features in first episode psychosis? Results from a 2-year follow-up study.European archives of psychiatry and clinical neuroscience · 2025
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Anne KästnerClinical Neuroscience, Max Planck Institute of Experimental Medicine, Hermann-Rein-Str.3, 37075, Göttingen, Germany. kaestner@em.mpg.de.
Martin BegemannClinical Neuroscience, Max Planck Institute of Experimental Medicine, Hermann-Rein-Str.3, 37075, Göttingen, Germany. begemann@em.mpg.de.
Tanja Maria MichelDepartment of Psychiatry, Institute for Clinical Research, University of Southern Denmark, Odense, Denmark. tmichel@health.sdu.dk.
Sarah EvertsClinical Neuroscience, Max Planck Institute of Experimental Medicine, Hermann-Rein-Str.3, 37075, Göttingen, Germany. everts@em.mpg.de.
Beata StepniakClinical Neuroscience, Max Planck Institute of Experimental Medicine, Hermann-Rein-Str.3, 37075, Göttingen, Germany. stepniak@em.mpg.de.
Christiane BachChild and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Mannheim, Germany. christiane.bach@zi-mannheim.de.
Luise PoustkaChild and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Mannheim, Germany. luise.poustka@zi-mannheim.de.
Joachim BeckerClinical Neuroscience, Max Planck Institute of Experimental Medicine, Hermann-Rein-Str.3, 37075, Göttingen, Germany. jbecker@gmx.net.
Tobias BanaschewskiChild and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Mannheim, Germany. tobias.banaschewski@zi-mannheim.de.
Matthias Dosekbo-Isar-Amper-Klinikum Taufkirchen, Taufkirchen (Vils), Germany. matthias.dose@kbo.de.
Hannelore EhrenreichClinical Neuroscience, Max Planck Institute of Experimental Medicine, Hermann-Rein-Str.3, 37075, Göttingen, Germany. ehrenreich@em.mpg.de.
Max Planck Society · DECentral Institute of Mental Health · DEIsar-Amper-Klinikum München-Ost · DENanoscale Microscopy and Molecular Physiology of the Brain Cluster of Excellence 171 — DFG Research Center 103 · DEUniversity of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBehavioral phenotypical continua from health to disease suggest common underlying mechanisms with quantitative rather than qualitative differences. Until recently, autism spectrum disorders and schizophrenia were considered distinct nosologic entities. However, emerging evidence contributes to the blurring of symptomatic and genetic boundaries between these conditions. The present study aimed at quantifying behavioral phenotypes shared by autism spectrum disorders and schizophrenia to prepare the ground for biological pathway analyses.

methodsSpecific items of the Positive and Negative Syndrome Scale were employed and summed up to form a dimensional autism severity score (PAUSS). The score was created in a schizophrenia sample (N = 1156) and validated in adult high-functioning autism spectrum disorder (ASD) patients (N = 165). To this end, the Autism Diagnostic Observation Schedule (ADOS), the Autism (AQ) and Empathy Quotient (EQ) self-rating questionnaires were applied back to back with the newly developed PAUSS.

resultsPAUSS differentiated between ASD, schizophrenia and a disease-control sample and substantially correlated with the Autism Diagnostic Observation Schedule. Patients with ADOS scores ≥12 obtained highest, those with scores <7 lowest PAUSS values. AQ and EQ were not found to vary dependent on ADOS diagnosis. ROC curves for ADOS and PAUSS resulted in AuC values of 0.9 and 0.8, whereas AQ and EQ performed at chance level in the prediction of ASD.

conclusionsThis work underscores the convergence of schizophrenia negative symptoms and autistic phenotypes. PAUSS evolved as a measure capturing the continuous nature of autistic behaviors. The definition of extreme-groups based on the dimensional PAUSS may permit future investigations of genetic constellations modulating autistic phenotypes.

Indexed as

PhenotypePsychiatric Status Rating ScalesAdultCase-Control StudiesChild Development Disorders, PervasiveDiagnostic ErrorsEmpathyFemaleHumansMaleMiddle AgedPsychometricsSchizophreniaSensitivity and SpecificitySeverity of Illness IndexSurveys and Questionnaires

Identifiers

PMID25968177
PMCPMC4436160
OpenAlexW1851854755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.